bullish

Poly Medicure

Poly Medicure (PLM IN): Placement to Fund Capex and M&A Initiatives Amid Favorable Demand Backdrop

121 Views28 Aug 2024 01:25
Poly Medicure raised INR10B via QIP. The company targets 20–22% growth from domestic market in FY25. The company is expanding manufacturing capacities and eyeing for acquisitions in next 6–8 months.
What is covered in the Full Insight:
  • Introduction
  • About the Company
  • Fund Raising Through QIP
  • Expanding Manufacturing Capacity
  • Market Presence and Growth Strategies
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Rising
Tina Banerjee
Global Healthcare Analyst
Health CareEquity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • Poly Medicure (PLM IN): Placement to Fund Capex and M&A Initiatives Amid Favorable Demand Backdrop
    28 Aug 2024
x